On Monday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.2 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.1. The stock opened at $27.52 ...

Gland Pharma Q2 Results Live : Gland Pharma declared their Q2 results on 04 Nov, 2024, reporting a topline increase of 2.36% ...

A South Florida company aims to grow its presence in Europe as more countries reconsider their policies on cannabis.

The US FDA has approved Vyloy in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of advanced gastric or gastroesophageal junction cancer.

Mexican-American Pablo Legorreta founded Royalty Pharma, which provides funding to pharmaceutical developers in exchange for ...

Quincy Jones worked with Michael Jackson on three of his albums. The pair had an incredibly successful working relationship, and Jones described Jackson as his brother following the latter’s death.

Both Harris and Trump made closing arguments to voters across swing states over the weekend and Monday. Each promised vastly ...

To help foot the bill to launch its approved graft-versus-host disease drug Niktimvo and the expected launch of its leukemia treatment revumenib, Syndax has struck a $350 million licensing deal with ...

Q3 2024 Earnings Call Transcript November 4, 2024 Revvity, Inc. misses on earnings expectations. Reported EPS is $0.935 EPS, ...

Henlius and Organon’s pertuzumab biosimilar met phase 3 goals; Meitheal expanded its US biosimilars; Celltrion’s subcutaneous infliximab (Zymfentra) showed monotherapy could be as effective as ...

Dividend Aristocrats represent a wide range of stocks in different industries, but each of these companies holds one ...

While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb ...